Cancer Pain Relief After Healing Touch and Massage.
Study Goal
The researchers aimed to compare the effectiveness of Healing Touch (HT) and Oncology Massage (OM) therapies in reducing pain among cancer patients.
Results Summary
Both HT and OM significantly reduced pain, with OM showing slightly better odds of clinically significant pain improvement when adjusted for pretherapy pain. However, for patients with severe pretherapy pain, OM was not more effective than HT in achieving significant pain reduction.
Population
572 cancer outpatients in an academic hybrid, multisite, community-based cancer institute.
Effective Dosage
Single session of either HT or OM.
Duration
Single session (duration not specified).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Healing Touch (HT) | decrease | pain | cancer outpatients | p < 0.01 | significantly reduced | #1 |
Oncology Massage (OM) | decrease | pain | cancer outpatients | p < 0.01 | significantly reduced | #2 |
Oncology Massage (OM) | increase | pain improvement | cancer outpatients | odds ratio (OR) 1.49 95% confidence interval (1.02-2.19) | was associated with increased odds of | #3 |
Oncology Massage (OM) | no change | clinically significant pain reduction | patients with severe pretherapy pain | p = 0.236 | was not more effective in yielding | #4 |
Healing Touch (HT) | decrease | immediate pain relief | cancer outpatients | - | provided | #5 |
Oncology Massage (OM) | decrease | immediate pain relief | cancer outpatients | - | provided | #6 |
OBJECTIVES: To establish and compare the effectiveness of Healing Touch (HT) and Oncology Massage (OM) therapies on cancer patients' pain. DESIGN: pretest/post-test, observational, retrospective study. SETTINGS/LOCATION: Outpatient oncology setting at an academic hybrid, multisite, community-based cancer institute. SUBJECTS: n = 572 cancer outpatients. INTERVENTIONS: Patients reported pain before and after receiving a single session of either HT or OM from a certified practitioner. OUTCOME MEASURES: Pain scores from 0 = no pain to 10 = worst possible pain. RESULTS: Two hundred ninety-one patients (50.9%) receiving HT and 281 (49.1%) receiving OM reported pretherapy and post-therapy pain. Pretherapy mean pain was higher in HT patients (M = 5.1, ±2.2) than OM (M = 4.4, ±2.2), p < 0.001; post-therapy mean pain remained higher in HT patients (M = 2.6, ±2.1) than OM (M = 2.0, ±1.8), p < 0.001. Both HT (p < 0.01) and OM (p < 0.01) significantly reduced pain. Unadjusted rates of clinically significant pain improvement (defined as ≥2-point reduction in pain score) were 0.68 HT and 0.71 OM. Adjusted for pretherapy pain, OM was associated with increased odds of pain improvement (odds ratio [OR] 1.49 95% confidence interval (1.02-2.19); p = 0.041). For patients with severe pretherapy pain, OM was not more effective in yielding clinically significant pain reduction (p = 0.236) when adjusting for pretherapy pain score. CONCLUSIONS: Both HT and OM provided immediate pain relief. Future research should explore the duration of pain relief, patient attitudes about HT compared with OM, and how this may differ among patients with varied pretherapy pain levels.